Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD: Case 1

home / case-based-peer-perspectives / metastatic-nsclc-case-1

Metastatic NSCLC with Corey J. Langer, MD, David Spigel, MD, Denise O'Dea, NP, and Jack West, MD

David Spigel, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

EP. 1: David Spigel, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

October 22nd 2015

Watch

David Spigel, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

EP. 2: David Spigel, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

October 22nd 2015

Watch

David Spigel, MD: Clinical Criteria for Dose Reduction

EP. 3: David Spigel, MD: Clinical Criteria for Dose Reduction

October 22nd 2015

Watch

David Spigel, MD: Concern About Drug Interactions

EP. 4: David Spigel, MD: Concern About Drug Interactions

October 22nd 2015

Watch

David Spigel, MD: Options for Treatment and Reimbursement After Dose Reduction

EP. 5: David Spigel, MD: Options for Treatment and Reimbursement After Dose Reduction

October 22nd 2015

Watch

Corey J. Langer, MD: Use of TKI Therapy in Patients With EGRF Exon 19 Deletion NSCLC

EP. 6: Corey J. Langer, MD: Use of TKI Therapy in Patients With EGRF Exon 19 Deletion NSCLC

October 22nd 2015

Watch

Corey J. Langer, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

EP. 7: Corey J. Langer, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

October 22nd 2015

Watch

Corey J. Langer, MD: Clinical Criteria for Dose Reduction

EP. 8: Corey J. Langer, MD: Clinical Criteria for Dose Reduction

October 22nd 2015

Watch

Corey J. Langer, MD: Concern About Drug Interactions

EP. 9: Corey J. Langer, MD: Concern About Drug Interactions

October 22nd 2015

Watch

Corey J. Langer, MD: Options for Treatment and Reimbursement After Dose Reduction

EP. 10: Corey J. Langer, MD: Options for Treatment and Reimbursement After Dose Reduction

October 22nd 2015

Watch

Denise O'Dea, NP: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

EP. 11: Denise O'Dea, NP: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

October 22nd 2015

Watch

Denise O'Dea, NP: Recommendations for Managing the Principle Adverse Event of Diarrhea

EP. 12: Denise O'Dea, NP: Recommendations for Managing the Principle Adverse Event of Diarrhea

October 22nd 2015

Watch

Denise O'Dea, NP: Clinical Criteria for Dose Reduction

EP. 13: Denise O'Dea, NP: Clinical Criteria for Dose Reduction

October 22nd 2015

Watch

Denise O'Dea, NP: Concern About Drug Interactions

EP. 14: Denise O'Dea, NP: Concern About Drug Interactions

October 22nd 2015

Watch

Denise O'Dea: Options for Treatment and Reimbursement After Dose Reduction

EP. 15: Denise O'Dea: Options for Treatment and Reimbursement After Dose Reduction

October 22nd 2015

Watch

Jack West, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

EP. 16: Jack West, MD: Use of TKI Therapy in Patients with EGRF Exon 19 Deletion NSCLC

October 22nd 2015

Watch

Jack West, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

EP. 17: Jack West, MD: Recommendations for Managing the Principle Adverse Event of Diarrhea

October 22nd 2015

Watch

Jack West, MD: Clinical Criteria for Dose Reduction

EP. 18: Jack West, MD: Clinical Criteria for Dose Reduction

October 22nd 2015

Watch

Jack West, MD: Concern About Drug Interactions

EP. 19: Jack West, MD: Concern About Drug Interactions

October 22nd 2015

Watch

Jack West, MD: Options for Treatment and Reimbursement After Dose Reduction

EP. 20: Jack West, MD: Options for Treatment and Reimbursement After Dose Reduction

October 22nd 2015

Watch